Sophie Robertson

Sophie Robertson
T: +44 (0) 121 654 5035
E: sophierobertson@catalystcf.co.uk

Sophie is a Senior Analyst in our Research team.

Her chief responsibilities are to produce detailed analysis of transaction trends in a variety of sectors and to provide bespoke research to support deal delivery. 

Sophie has supported the delivery of a number of transactions including the merger of Options Group with Outcomes First Group, the sales of Raphael Healthcare and Focus Pharmaceuticals, and the management buy-outs of Armitage Pet Care and 4Ways Healthcare.

Sophie is a member of the Healthcare sector team. She also has a particular focus on the Education & Training and Speciality Food Ingredients sectors. 

Sophie has a degree in Philosophy from Durham and BSc in Banking and Finance, and is a fluent Spanish speaker.

Record Year for M&A in Medical Devices

2015 was a very strong year for M&A in the UK for medical devices businesses with the sector recording 64 deals compared to 51... 

Nikon becomes latest consumer brand to enter the Medtech market

The growing convergence between the consumer and healthcare sectors has been further demonstrated today 

New legislation creating unprecedented opportunities for clued up SEN providers

The Children and Families Act 2014, in the process of being implemented, introduces radical changes... 

Oasis Healthcare acquires Smiles Dental

Consolidation in the dental market is continuing with Oasis Healthcare’s acquisition of Smiles Dental, in a deal which… 

Catalyst advises Spectris plc on its acquisition of Concept Life Sciences

Catalyst Corporate Finance has advised Spectris plc, the productivity-enhancing instrumentation and controls company, on its acquisition of Concept Life Sciences.  

Advisor to WernerCo and Triton Partners on the acquisition of Zarges Group

We advised WernerCo and Triton Partners on the acquisition of Zarges Group, a leading provider of professional access, storage and special construction solutions. 

Catalyst advises Piper on investment in Neom Organics

Catalyst has advised Piper on its investment in beauty and wellbeing brand Neom Organics (“Neom”). 

Catalyst advises Synova on 4Ways Healthcare refinancing

We advised Synova Capital on its refinancing of portfolio company 4Ways Healthcare, a leading provider of tele-diagnostic services to the healthcare sector.  

Catalyst advises PCMS Group on its sale to a management buy-out team backed by Inflexion Private Equity

Catalyst has advised PCMS Group, a leading provider of point-of-sale software and services for major retailers, on its sale to a management buy-out team, backed by Inflexion.